IndonesiaSingaporeMalaysiaVietnamThailandPhilippinesMyanmar
IndiaGreater ChinaRest of AsiaWorld
E-Commerce & Internet EconomyTechnologyReal Estate and InfrastructureFinancial ServicesSocial Infrastructure
Partner ContentDeals Barometer

Malaysian PE firm Ekuinas acquires 80% stake in pharma player Symbiotica

Malaysian PE firm Ekuinas acquires 80% stake in pharma player Symbiotica

Ekuinas CEO Syed Yasir Arafat Syed Abd Kadir at DEALSTREETASIA's PE-VC Summit 2018 in Singapore.

Malaysia’s state-owned private equity firm Ekuiti Nasional Bhd (Ekuinas) announced that it has acquired an 80% stake in active pharmaceutical ingredient (API) manufacturer Symbiotica Specialty Ingredients (Symbiotica).

Edited by: Padma Priya

EkuinasSymbiotica

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter

Related Stories

Deals

Malaysian PE firm Ekuinas sells 50% stake in oil & gas firm Icon Offshore

The sale reduced Ekuinas' stake in ICON to 5.8%.

Private Equity

Malaysia's Ekuinas books $137m return from second fund in 2020

The fund generated a gross internal rate of return (IRR) of 11.9% per annum and a net IRR of 8.2%.
Nikkei Logo
DealStreetAsia Logo
About Us
Team
Advertise
Contact
Careers
Blog
Privacy Policy
Terms & Conditions
© Copyright DEALSTREETASIA 2014-2024 All rights reserved.